pictured: David Jones
Q&A
By Christina Pernambuco-Holsten, MA  |  Wednesday, August 13, 2014

David Jones, Chief of the Thoracic Surgery Service, talks about what makes MSK thoracic surgeons special and where he believes the future of treatment for cancers of the lung and esophagus is headed.

Pictured: Richard O’Reilly
In the Clinic
By Jim Stallard, MA, Writer/Editor  |  Thursday, July 31, 2014

A study shows that treatment of severe combined immunodeficiency (SCID) with stem cell transplantation is very effective, especially if done early.

Pictured: Robotic surgery
In the Clinic
By Eva Kiesler, PhD, Science Writer/Editor  |  Thursday, July 24, 2014

Memorial Sloan Kettering researchers have found that the use of surgical robots does not lead to better outcomes in patients undergoing radical cystectomy for bladder cancer, bringing into question the added costs of the tools.

Pictured: Gabriela Chiosis
Finding
By Celia Gittelson, BA  |  Thursday, July 17, 2014

A small molecule discovered at MSK called PU-H71 blocks the growth of cancer cells and enables doctors to image tumors.

Pictured: Vivian Strong
Cancer Guide
By Andrea Peirce, BA, Writer/Editor  |  Tuesday, June 24, 2014

Memorial Sloan Kettering diagnoses and treats more people with stomach cancer than any other cancer center in the nation.

Pictured: Peter Allen
In the Clinic
By Jim Stallard, MA, Writer/Editor  |  Wednesday, June 18, 2014

A new drug could make pancreatic surgery safer by reducing the risk of a grave complication.

Pictured: Larry Norton
Video
By Helen Garey, MPH, Freelance Writer  |  Tuesday, June 10, 2014

Memorial Sloan Kettering experts say that new information about the biology of breast cancer is revolutionizing the way they look at the disease.

Pictured: Jedd Wolchok
MSK at ASCO
By Media Staff  |  Wednesday, June 4, 2014

Our experts offer their perspective in major media outlets on recent research into drug- and cell-based immunotherapies for cancer.

Pictured: Helen McArthur
In the Clinic
By Julie Grisham, MS, Science Writer/Editor  |  Tuesday, June 3, 2014

The treatment combines a technique called cryoablation, or freezing of the tumor, with an immunotherapy drug.

Pictured: David Solit
Profile
By Julie Grisham, MS, Science Writer/Editor  |  Tuesday, May 27, 2014

David Solit, Director of the Marie-Josée and Henry R. Kravis Center for Molecular Oncology, discusses how working with cancer patients drives him to develop more-effective, personalized cancer treatments.

Pictured: Tari King
In the News
By Jennifer Bassett, MA, Writer/Editor  |  Thursday, May 22, 2014

Memorial Sloan Kettering breast surgeon Tari King talks to CBS Online about a new study suggesting double mastectomies may be performed unnecessarily in many women.

Pictured: Mark Kris
Finding
By Julie Grisham, MS, Science Writer/Editor  |  Wednesday, May 21, 2014

A new study has found that driver mutations can be found in about two-thirds of lung adenocarcinomas, suggesting options for treatment with targeted therapies.

Pictured: José Baselga, Agnès Viale,  Michael Berger & David Solit
Announcement
By Eva Kiesler, PhD, Science Writer/Editor  |  Tuesday, May 20, 2014

With the creation of the Marie-Josée and Henry R. Kravis Center for Molecular Oncology, Memorial Sloan Kettering sets out to deliver on the promise of personalized medicine by creating better treatment options for all people with cancer.

pictured: Martin S. Tallman
Profile
By Maureen Salamon, BA, Freelance Writer  |  Monday, May 19, 2014

Leukemia Specialist Martin Tallman discusses how research has led to improvements in the treatment of leukemia and what challenges remain.

Pictured: William Tap
MSK at ASCO
By Media Staff  |  Thursday, May 15, 2014

New Memorial Sloan Kettering research demonstrates the powerful clinical benefit of giving patients a drug that targets the molecular abnormality driving the growth of a rare and debilitating joint disease.

Center News

Stay Informed

Get the latest information about cancer care and research every month.